What is Abbott's stock-based comp?

Abbott (ABT) reported stock-based comp of $317M in Q1 2026.

How has Abbott's stock-based comp changed year-over-year?

Abbott's stock-based comp increased by 9.7% year-over-year, from $289M to $317M.

What is the long-term trend for Abbott's stock-based comp?

Over 4 years (2021 to 2025), Abbott's stock-based comp has grown at a 0.9% compound annual growth rate (CAGR), from $640M to $664M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Abbott ABT Stock-Based Comp

Stock-Based Comp at other companies

Becton, Dickinson and CompanyBDX

$58M+41.5%

Johnson & JohnsonJNJ

$300M+4.2%

HaemoneticsHAE

$9.13M+31.6%

ArtivionAORT

$8.41M+4.6%

Merit Medical SystemsMMSI

$8.96M-1.3%

Boston ScientificBSX

$83M+12.2%

Other financials

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.1%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

See full

Market cap$163.94B-31.8%

Enterprise value$191.18B-22.5%

P/E26.1×+8.9×

P/S3.6×-1.9×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

FCF margin16.3%+0.6pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's stock-based comp?: Abbott (ABT) reported stock-based comp of $317M in Q1 2026.
How has Abbott's stock-based comp changed year-over-year?: Abbott's stock-based comp increased by 9.7% year-over-year, from $289M to $317M.
What is the long-term trend for Abbott's stock-based comp?: Over 4 years (2021 to 2025), Abbott's stock-based comp has grown at a 0.9% compound annual growth rate (CAGR), from $640M to $664M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.